Geneos Wealth Management Inc. Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Geneos Wealth Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $330,240 - $428,759	-3,000 Reduced 96.77%	100 $11,000
Q4 2021 Feb 09, 2022	BUY	$99.73 - $148.48 $299,190 - $445,439	3,000 Added 3000.0%	3,100 $427,000
Q2 2021 Jul 08, 2021	SELL	$65.78 - $105.02 $1,644 - $2,625	-25 Reduced 20.0%	100 $9,000
Q4 2020 May 19, 2021	BUY	$65.07 - $98.24 $1,626 - $2,456	25 Added 25.0%	125 $6,000
Q4 2019 Sep 07, 2021	BUY	$40.86 - $57.65 $4,086 - $5,765	100 New	100 $5,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.